209 related articles for article (PubMed ID: 32678895)
1. Iron chelation rescues hemolytic anemia and skin photosensitivity in congenital erythropoietic porphyria.
Blouin JM; Ged C; Lalanne M; Lamrissi-Garcia I; Morice-Picard F; Costet P; Daher R; Moreau-Gaudry F; Bedel A; Puy H; Gouya L; Karim Z; Richard E
Blood; 2020 Nov; 136(21):2457-2468. PubMed ID: 32678895
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic potential of proteasome inhibitors in congenital erythropoietic porphyria.
Blouin JM; Duchartre Y; Costet P; Lalanne M; Ged C; Lain A; Millet O; de Verneuil H; Richard E
Proc Natl Acad Sci U S A; 2013 Nov; 110(45):18238-43. PubMed ID: 24145442
[TBL] [Abstract][Full Text] [Related]
3. Genetic background influences hepcidin response to iron imbalance in a mouse model of hemolytic anemia (Congenital erythropoietic porphyria).
Lefebvre T; Millot S; Richard E; Blouin JM; Lalanne M; Lamrissi-Garcia I; Costet P; Lyoumi S; Gouya L; Puy H; Moreau-Gaudry F; de Verneuil H; Karim Z; Ged C
Biochem Biophys Res Commun; 2019 Dec; 520(2):297-303. PubMed ID: 31601421
[TBL] [Abstract][Full Text] [Related]
4. ALAS2 acts as a modifier gene in patients with congenital erythropoietic porphyria.
To-Figueras J; Ducamp S; Clayton J; Badenas C; Delaby C; Ged C; Lyoumi S; Gouya L; de Verneuil H; Beaumont C; Ferreira GC; Deybach JC; Herrero C; Puy H
Blood; 2011 Aug; 118(6):1443-51. PubMed ID: 21653323
[TBL] [Abstract][Full Text] [Related]
5. Identification of novel
Blouin JM; Ged C; Bernardo-Seisdedos G; Cabantous T; Pinson B; Poli A; Puy H; Millet O; Gouya L; Morice-Picard F; Richard E
Mol Genet Metab Rep; 2021 Jun; 27():100722. PubMed ID: 33659185
[TBL] [Abstract][Full Text] [Related]
6. Inducing iron deficiency improves erythropoiesis and photosensitivity in congenital erythropoietic porphyria.
Egan DN; Yang Z; Phillips J; Abkowitz JL
Blood; 2015 Jul; 126(2):257-61. PubMed ID: 25972160
[TBL] [Abstract][Full Text] [Related]
7. Advances in understanding the pathogenesis of congenital erythropoietic porphyria.
Di Pierro E; Brancaleoni V; Granata F
Br J Haematol; 2016 May; 173(3):365-79. PubMed ID: 26969896
[TBL] [Abstract][Full Text] [Related]
8. Congenital erythropoietic porphyria: Recent advances.
Erwin AL; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):288-297. PubMed ID: 30685241
[TBL] [Abstract][Full Text] [Related]
9. Congenital erythropoietic porphyria: dilemmas in present day management.
Dawe SA; Peters TJ; Du Vivier A; Creamer JD
Clin Exp Dermatol; 2002 Nov; 27(8):680-3. PubMed ID: 12472546
[TBL] [Abstract][Full Text] [Related]
10. Congenital erythropoietic porphyria: prolonged high-level expression and correction of the heme biosynthetic defect by retroviral-mediated gene transfer into porphyric and erythroid cells.
Kauppinen R; Glass IA; Aizencang G; Astrin KH; Atweh GF; Desnick RJ
Mol Genet Metab; 1998 Sep; 65(1):10-7. PubMed ID: 9787090
[TBL] [Abstract][Full Text] [Related]
11. Congenital erythropoietic porphyria and erythropoietic protoporphyria: Identification of 7 uroporphyrinogen III synthase and 20 ferrochelatase novel mutations.
Weiss Y; Balwani M; Chen B; Yasuda M; Nazarenko I; Desnick RJ
Mol Genet Metab; 2019 Nov; 128(3):358-362. PubMed ID: 30454868
[TBL] [Abstract][Full Text] [Related]
12. Uroporphyrinogen III synthase knock-in mice have the human congenital erythropoietic porphyria phenotype, including the characteristic light-induced cutaneous lesions.
Bishop DF; Johansson A; Phelps R; Shady AA; Ramirez MC; Yasuda M; Caro A; Desnick RJ
Am J Hum Genet; 2006 Apr; 78(4):645-58. PubMed ID: 16532394
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of congenital erythropoietic porphyria using matched unrelated hematopoietic stem cell transplantation.
Martinez Peinado C; Díaz de Heredia C; To-Figueras J; Arias-Santiago S; Nogueras P; Elorza I; Olivé T; Bádenas C; Moreno MJ; Tercedor J; Herrero C
Pediatr Dermatol; 2013; 30(4):484-9. PubMed ID: 23557135
[TBL] [Abstract][Full Text] [Related]
14. A knock-in mouse model of congenital erythropoietic porphyria.
Ged C; Mendez M; Robert E; Lalanne M; Lamrissi-Garcia I; Costet P; Daniel JY; Dubus P; Mazurier F; Moreau-Gaudry F; de Verneuil H
Genomics; 2006 Jan; 87(1):84-92. PubMed ID: 16314073
[TBL] [Abstract][Full Text] [Related]
15. Correction of deficient CD34+ cells from peripheral blood after mobilization in a patient with congenital erythropoietic porphyria.
Mazurier F; Géronimi F; Lamrissi-Garcia I; Morel C; Richard E; Ged C; Fontanellas A; Moreau-Gaudry F; Morey M; de Verneuil H
Mol Ther; 2001 Mar; 3(3):411-7. PubMed ID: 11273784
[TBL] [Abstract][Full Text] [Related]
16. Interdependence between degree of porphyrin excess and disease severity in congenital erythropoietic porphyria (Günther's disease).
Freesemann AG; Bhutani LK; Jacob K; Doss MO
Arch Dermatol Res; 1997 Apr; 289(5):272-6. PubMed ID: 9164637
[TBL] [Abstract][Full Text] [Related]
17. Missense UROS mutations causing congenital erythropoietic porphyria reduce UROS homeostasis that can be rescued by proteasome inhibition.
Blouin JM; Bernardo-Seisdedos G; Sasso E; Esteve J; Ged C; Lalanne M; Sanz-Parra A; Urquiza P; de Verneuil H; Millet O; Richard E
Hum Mol Genet; 2017 Apr; 26(8):1565-1576. PubMed ID: 28334762
[TBL] [Abstract][Full Text] [Related]
18. Very Early Diagnosis and Management of Congenital Erythropoietic Porphyria.
Desjardins MP; Naccache L; Hébert A; Auger I; Teira P; Pelland-Marcotte MC
Clin Pediatr (Phila); 2023 Jun; 62(5):399-403. PubMed ID: 36217751
[TBL] [Abstract][Full Text] [Related]
19. Porphyrins in urine, plasma, erythrocytes, bile and faeces in a case of congenital erythropoietic porphyria (Gunther's disease) treated with blood transfusion and iron chelation: lack of benefit from oral charcoal.
Gorchein A; Guo R; Lim CK; Raimundo A; Pullon HW; Bellingham AJ
Biomed Chromatogr; 1998; 12(6):350-6. PubMed ID: 9861496
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
